Hints and tips:
Related Special Reports
...There are approximately 450 claims filed in federal courts against Mead Johnson and rival manufacturer Abbott Laboratories in relation to NEC, grouped together under one judge....
...The US drugmaker last year launched a collaboration with digital health company Ada Health to help patients understand if they met criteria to be prescribed Covid treatments such as Paxlovid....
...A key plank of the NHS’s current infrastructure plan is the “new hospital programme”, backed by more than £20bn in government funding....
...UL Solutions, a Chicago-based safety testing and certification group, is pushing ahead with plans for one of the largest initial public offerings of the year despite a mixed reception for recent listings...
...research laboratory, known as its “Vision Lab”, in the city....
...However, the business made back some its losses when it boosted US sales during a national baby formula shortage, after competitor Abbott Laboratories closed a factory following reports of bacterial infections...
...Creditors will vote on May 30 whether to approve the restructuring plan. Here’s more on the creditors and the deal they have proposed....
...The company will now focus on a plan to reach 3 to 5 per cent comparable growth by 2025, he said....
...Others in the sector were down more than 3 per cent, including Solventum, the healthcare group that was spun out from 3M earlier this week....
...A University of Edinburgh study this year found cycle commuting “reduced mental ill-health”....
...“Because organoids can be made from human cells, they can model aspects of human biology that cannot be captured in animal testing,” said Lancaster, group leader at the UK Medical Research Council Laboratory...
...But given the transformative nature of the treatment for a disease with a poor prognosis, the high list price has not held back sales for the pharma group....
...Beijing-based Joinn Laboratories, which acquired two lab animal suppliers in 2022, has warned about the impact of falling primate prices on its business....
...Aardvark plans to use the proceeds from its pre-IPO round to fund a late-stage clinical study into ARD-101’s efficacy on Prader-Willi patients and into patients withdrawing from GLP-1 drugs after weight...
...An official from a non-profit environmental group said the US stance risked depriving the rest of the world of a stricter treaty....
...In March, officials from 194 countries came together to agree on a global plan to deal with a threat known as “Disease X”....
...The biggest movers on European bourses on Tuesday include retailer Casino, engineering company GTT, fund manager Abrdn and laboratory group Eurofins....
...The positive data will also be a boon to Eli Lilly’s efforts to push for more widescale coverage of the drugs by private insurers and US federal health insurance programme Medicare, which were both initially...
...The shortage was exacerbated by the closure of a baby formula factory belonging to Abbott Laboratories, the second-biggest US supplier, after reports of bacterial infections in babies....
...Pharma groups contest the lab’s results and practices....
...Companies: Abbott Laboratories and infrastructure company Kinder Morgan are scheduled to report first-quarter earnings. Five more top stories 1....
...Laboratories Q1, ASML Q1, Citizens Financial Group Q1, Financial Services Q1, Hays Q3 trading statement, Las Vegas Sands Corp Q1, United Airlines Q1 Thursday US: G20 finance ministers meeting Results...
...About 40 per cent of the votes cast at the group’s annual meeting in 2021 were against the remuneration plan, which is set every three years....
...Up to 15 per cent of the fund is in unquoted stocks managed by SV Health Investors, the VC group run by Kate Bingham, former chair of the UK’s vaccine taskforce....
...Cuban is targeting the 38 per cent of private sector employers who self-insure at least one of their health plans....
International Edition